Alzheimer’s disease-associated complement gene variants influence plasma complement protein levels

被引：0

作者：

Aurora Veteleanu

Joshua Stevenson-Hoare

Samuel Keat

Nikoleta Daskoulidou

Henrik Zetterberg

Amanda Heslegrave

Valentina Escott-Price

Julie Williams

Rebecca Sims

Wioleta M. Zelek

Sarah M. Carpanini

Bryan Paul Morgan

机构：

[1] Cardiff University,UK Dementia Research Institute Cardiff, School of Medicine

[2] Cardiff University,Neurosciences and Mental Health Institute

[3] UK Dementia Research Institute at University College London,Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Psychology

[4] The Sahlgrenska Academy at the University of Gothenburg,Clinical Neurochemistry Laboratory

[5] Sahlgrenska University Hospital,Department of Neurodegenerative Disease

[6] UCL Institute of Neurology,Division of Psychological Medicine and Clinical Neurosciences

[7] Queen Square,undefined

[8] Hong Kong Center for Neurodegenerative Diseases,undefined

[9] Cardiff University,undefined

来源：

Journal of Neuroinflammation | / 20卷

关键词：

Alzheimer’s disease; Complement system; Biomarkers; Clusterin; Complement receptor 1; C1s; C1q; Factor H; GWAS;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 365 条

[1] Wittenberg R(2019)Economic impacts of introducing diagnostics for mild cognitive impairment Alzheimer's disease patients Alzheimers Dement (N Y) 5 382-387
[2] Knapp M(2002)The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics Science 297 353-356
[3] Karagiannidou M(2018)Postsynaptic proteome of non-demented individuals with Alzheimer's disease neuropathology J Alzheimers Dis 65 659-682
[4] Dickson J(2018)NIA-AA research framework: toward a biological definition of Alzheimer's disease Alzheimers Dement 14 535-562
[5] Schott JM(2021)Use of plasma biomarkers for AT(N) classification of neurodegenerative dementias J Neurol Neurosurg Psychiatry 92 1206-1214
[6] Hardy J(2021)Prediction of future Alzheimer's disease dementia using plasma phospho-tau combined with other accessible measures Nat Med 27 1034-1042
[7] Selkoe DJ(2022)Obesity as a risk factor for dementia and Alzheimer's disease: the role of leptin Int J Mol Sci 23 5202-775
[8] Zolochevska O(2022)Type 2 diabetes mellitus as a risk factor for Alzheimer's disease: review and meta-analysis Biomedicines 10 778-176
[9] Bjorklund N(2022)The risk of dementia in patients with inflammatory bowel disease: a systematic review and meta-analysis Int J Colorectal Dis 37 769-346
[10] Woltjer R(2014)Raised serum proinflammatory cytokines in Alzheimer's disease with depression Aging Dis 5 170-66